Enantiomeric quality control of antihistamines in pharmaceuticals by affinity electrokinetic chromatography with human serum albumin as chiral selector

The present paper deals with the enantiomeric separation of six antihistaminic enantiomers by affinity electrokinetic chromatography (AEKC)-partial filling technique using human serum albumin (HSA) as chiral selector. A multivariate optimization approach of the most critical experimental variables in enantioresolution, running pH, HSA concentration and HSA plug length (SPL) was carried out since there are interactions between variables that could not be considered in an univariate optimization. The estimated and experimental resolution values obtained for antihistaminic enantiomers varied from 1.13 (for orphenadrine) to 2.15 (for brompheniramine). The optimum experimental conditions for enantioresolution of each compound were: brompheniramine, pH 8.5, [HSA] 180 μM, SPL 180 s; chlorcyclizine, pH 6.5, [HSA] 180 μM, SPL 150 s; chlorpheniramine, pH 8.25, [HSA] 160 μM, SPL 150 s; hydroxyzine, pH 7.0, [HSA] 180 μM, SPL 150 s; and orphenadrine, pH 7.8, [HSA] 160 μM, SPL 150 s. pH and the quadratic term of pH seem to be the most critical factors that determine enantioresolution of antihistamines. The validity of the developed methodologies to enantiomeric quality control of antihistamines in pharmaceutical formulations is demonstrated analyzing the content of brompheniramine, chlorpheniramine and hyroxyzine enantiomers in commercially available pharmaceutical formulations containing racemic mixtures of compounds. Resolution, accuracy, reproducibility, cost and sample throughput of the proposed methodologies make them suitable for quality control of the enantiomeric composition of antihistamines in pharmaceutical preparations.     

Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations

A stability indicating, reversed-phase ion-pair high-performance liquid chromatographic method was developed and validated for the determination of risedronate in pharmaceutical dosage forms. The determination was performed on a BDS C₁₈ analytical column (250 mm × 4.6 mm i.d., 5 μm particle size); the mobile phase consisted of 0.005 M tetrabutylammonium hydroxide and 0.005 M pyrophosphate sodium (pH 7.0) mixed with acetonitrile in a ratio (78:22, v/v) and pumped at a flow rate 1.00 mL min⁻¹. The ultraviolet (UV) detector was operated at 262 nm. The retention times of magnesium ascorbyl phosphate, which was used as internal standard and risedronate were 4.94 and 5.95 min, respectively. The calibration graph was ranged from 2.50 to 20.00 μg mL⁻¹, while detection and quantitation limits were found to be 0.48 and 1.61 μg mL⁻¹, respectively. The intra- and inter-day percentage relative standard deviations, %R.S.D., were less than 5.9%, while the relative percentage error, %E_r, was less than 0.4%. The method was applied to the quality control of commercial tablets and content uniformity test and proved to be suitable for rapid and reliable quality control.     

Determination of NSAIDs in river sediment samples

Consumption of non-steroidal anti-inflammatory drugs (NSAIDs) is increasing and with it the danger of environmental pollution by pharmaceutical residues. Publications regarding NSAIDs in the environment not only show that they are toxic to many animal species, but also highlight the need for robust analytical methods for monitoring the level of such contaminants in environmental matrices. In our study we selected the four most widely used NSAIDs in Slovenia and Central Europe, ibuprofen, naproxen, ketoprofen and diclofenac, and studied their extraction from sediment samples. We examined several extraction techniques (ultrasonic extraction, Soxhlet extraction, pressurized liquid extraction, supercritical fluid extraction and microwave-assisted extraction) using a spiked sediment sample and determined optimal extraction conditions. After extraction we applied a clean-up step, derivatisation of the analytes and gas chromatography with mass spectrometric detection (GC-MSD) and selected the most appropriate extraction procedure. The optimised analytical method chosen for analysis of sediment samples consisted of microwave-assisted extraction, clean-up of the extract with SPE, derivatisation with MSTFA and determination with GC-MSD. The optimised procedure was applied to the analysis of two environmental river samples taken from the vicinity of Novo mesto, the biggest town in the south eastern part of Slovenia with 62,000 inhabitants, a hospital and a pharmaceutical factory in its vicinity. While analysis of the sample taken upstream of the town showed no detectable amounts of NSAIDs, analysis of samples taken downstream showed quantifiable levels of two of the studied NSAIDs (naproxen and ketoprofen). Besides these two NSAIDs, river water samples sampled at the same time and location on the River Krka also showed the presence of diclofenac. Sampling on the River Krka and other Slovene rivers will in the future be repeated at different sampling points in order to track down the main sources of pollution.     

Development of membrane electrodes for selective determination of some antiepileptic drugs in pharmaceuticals,plasma and urine

Newly developed, simple, low-cost and sensitive ion-selective electrodes have been proposed for determination of some antiepileptic drugs such as lamotrigine, felbamate, and primidone in their pharmaceutical preparations as well as in biological fluids. The electrodes are based on poly(vinyl chloride) membranes doped with drug–tetraphenyl borate (TPB) or drug–phosphotungstic acid (PT) ion-pair complexes as molecular recognition materials. The novel electrodes displayed rapid Nernstian responses with detection limits of approximately 10⁻⁷ M. Calibration graphs were linear over the ranges 5.2 × 10⁻⁷–1.0 × 10⁻³, 1.5 × 10⁻⁶–1.0 × 10⁻³, and 2.6 × 10⁻⁷–1.0 × 10⁻³ M for drug–TPB and 5.8 × 10⁻⁷–1.0 × 10⁻³, 1.8 × 10⁻⁷–1.0 × 10⁻³, and 6.6 × 10⁻⁷–1.0 × 10⁻³ M for drug–PT electrodes, respectively, with slopes ranging from 52.3 to 62.3 mV/decade. The membranes developed have potential stability for up to 1 month and proved to be highly selective for the drugs investigated over other ions and excipients. The results show that the selectivity of the ion-selective electrodes is influenced significantly by the plasticizer. The proposed electrodes were successfully applied in the determination of these drugs in pharmaceutical preparations in four batches of different expiry dates. Statistical Student’s t test and F test showed insignificant systematic error between the ion-selective electrode methods developed and a standard method. Comparison of the results obtained using the proposed electrodes with those found using a reference method showed that the ion-selective electrode technique is sensitive, reliable, and can be used with very good accuracy and high percentage recovery without pretreatment procedures of the samples to minimize interfering matrix effects. Figure Structure of lamotrigine, felbanate and primidone     

Determination of ascorbic acid in pharmaceutical dosage forms and urine by means of an oscillatory reaction system using the pulse perturbation technique

A simple and reliable method for the determination of ascorbic acid (AA) is proposed and validated. It is based on potentiometric monitoring of the concentration perturbations of an oscillatory reaction system in a stable nonequilibrium stationary state close to the bifurcation point. The response of the Bray–Liebhafsky (BL) oscillatory reaction as a matrix, to the perturbation by different concentrations of AA, is followed by a Pt electrode. The linear relationship between maximal potential shift and the logarithm of the amount of AA is obtained between 0.01 and 1.0 μmol. The sensitivity of the proposed method (as the limit of detection) is 0.009 μmol and the method has excellent sample throughput (30 samples per hour). The procedure was used for AA determination in pharmaceutical formulations and urine. The results are in agreement with those obtained using the official method. Some aspects of the possible mechanism of AA action on the BL oscillating chemical system are discussed.     

Room-temperature,phosphorimetric determination of the beta-blocking agent pindolol in pharmaceutical tablets,urine and blood serum

It is already recognised that heavy-atom-induced, room-temperature phosphorescence can be used to determine pindolol in pharmaceutical samples and biological fluids. We describe here a new, simple, rapid and selective development of this technique. The phosphorescence signals derive from the interaction of pindolol with a relatively high concentration of heavy-atom salts in the presence of sodium sulphite as oxygen scavenger. Phosphorescence was registered in the presence of 1.2 M potassium iodide, 15 mM sodium sulphite and 30% v/v methanol at 450 nm, exciting at 285 nm. The detection limit was 21.1 ng mL⁻¹. The method has been successfully applied to the determination of pindolol in commercial pharmaceutical tablets, urine and blood serum.     

Comparative validation of amisulpride determination in pharmaceuticals by several chromatographic, electrophoretic and spectrophotometric methods

Depleted uranium (DU) is a by-product of the uranium enrichment process for nuclear fuel. According to the Commission Decision 2002/657/EC, a confirmatory method for the quantification of DU in freeze-dried fish was developed by isotope ratio dynamic reaction cell inductively coupled plasma-mass spectrometry (IR-DRC-ICP-MS). A preliminary study was performed to determine the following parameters: instrumental detection limit (IDL), isotopic ratio measurement limit (IRML), percentage of DU (P(DU)) in presence of natural uranium (NU) and limit of quantification (LoQ(DU)). The analyses were carried out by means of IR-DRC-ICP-MS. Ammonia was the reaction gas used for the dynamic reaction cell. In addition, a sector field inductively coupled plasma mass spectrometer (SF-ICP-MS) was employed to calculate the within-laboratory reproducibility. For the confirmatory method the following parameters were determined: (a) trueness; (b) precision; (c) critical concentrations alpha and beta (CC(alpha), CC(beta)); (d) specificity; (e) stability. Trueness was assessed by using the recovery tests. The recovery and within-laboratory reproducibility were determined by fortifying the blank digested solution of dogfish tissue: six aliquots were fortified at 1, 1.5 and 2 times the LOQ(DU) with 25.0, 37.5 and 50.0 ng L(-1) or 4.16, 6.24, 8.32 microg kg(-1) with a recovery of -8.2, +9.5 and +9.6%, respectively and a within-laboratory reproducibility (three analytical run) of 15.5, 8.0 and 11.0%, respectively. The results for the decision limit and the detection capability were: CC(alpha) = 11.69 ng L(-1) and CC(beta) = 19.8 ng L(-1). The digested solutions resulted to be stable during testing time (60 days) and the method can be considered highly specific as well.     

深度卷积网络的多品种多厂商药品近红外光谱分类

近红外光谱（NIR）分析具有分析高效、样品无损、环境无污染以及可现场检测等优点,特别适合药品的快速建模分析。但NIR存在吸收强度弱以及谱带重叠等缺点,需要建立稳健可靠的化学计量学模型对其进行分析。深度卷积神经网络是深度学习方法中一个重要分支,它通过逐层抽取数据特征并进行组合、转换,形成更高层的语义特征,具有极强的建模能力,广泛应用于计算机视觉、语音识别等领域,而在药品NIR分析方面尚未见报道。基于深度卷积网络模型,对药品NIR多分类建模进行研究。针对药品NIR数据的特点,设计若干个面向多品种、多厂商药品NIR分类的一维深度卷积网络模型。模型中卷积层和池化层交叠排列用于逐层抽取NIR数据特征,输出层连接softmax分类器,对药品NIR数据进行分类概率预测。在输出层之前采用全局最大池化层,将特征图进行整体池化,形成一个特征点,用于解决全连接层存在的限制输入维度大小,参数过多的问题。同时,在网络模型中引入批处理操作和dropout机制,以防止梯度消失和减小网络过拟合的风险。在网络模型的设计过程中,通过设计不同的卷积网络层数以及不同的卷积核尺寸大小,分析其对建模效果的影响,同时分析五种经典数据预处理方法对NIR分析的影响。以我国7个厂商生产的头孢克肟片和11个厂商生产的苯妥英钠片样本NIR为实验对象, 建立药品的多品种、多厂商分类模型,该模型在二分类、多分类实验中取得了良好的分类效果。在十八分类实验中,当训练集与测试集比例为7∶3时,分类准确率为99.37±0.45,比SVM, BP, AE和ELM算法取得更优的分类性能。同时,深度卷积神经网络模型推理速度较快,优于SVM和ELM算法,但训练速度慢于二者。大量实验结果表明,深度卷积神经网络可对多品种、多厂商药品NIR数据准确、可靠地判别分类,且模型具有良好的鲁棒性和可扩展性。该方法也可推广到烟草、石化等其他领域的NIR数据分类应用中。     

Spectrofluorimetric Determination of Fluvoxamine in Dosage Forms and Plasma Via Derivatization with 4-Chloro-7-Nitrobenzo-2-Oxa-1,3-Diazole

A highly sensitive and simple spectrofluorimetric method has been developed and validated for the determination of the antidepressant fluvoxamine (FXM) in its dosage forms and plasma. The method was based on nucleophilic substitution reaction of FXM with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole in an alkaline medium (pH 8) to form a highly fluorescent derivative that was measured at 535 nm after excitation at 470 nm. The factors affecting the reaction was carefully studied and optimized. The kinetics of the reaction was investigated, and the reaction mechanism was presented. Under the optimized conditions, linear relationship with good correlation coefficient (0.9995) was found between the fluorescence intensity and FXM concentration in the range of 65–800 ng ml⁻¹. The limits of detection and quantitation for the method were 21 and 64 ng ml⁻¹, respectively. The precision of the method was satisfactory; the values of relative standard deviations did not exceed 2.17%. The proposed method was successfully applied to the determination of FXM in its pharmaceutical tablets with good accuracy; the recovery values were 97.8–101.4 ± 1.08–2.75%. The results obtained by the proposed method were comparable with those obtained by the official method. The high sensitivity of the method allowed its successful application to the analysis of FXM in spiked human plasma. The proposed method is superior to the previously reported spectrofluorimetric method for determination of FXM in terms of its simplicity. The proposed method is practical and valuable for its routine application in quality control and clinical laboratories for analysis of FXM.     

吡洛昔康的极谱测定

在0.06mol/LHAc NaAc(pH4.5±0.1)缓冲溶液中,吡洛昔康于-1.23V(vs.SCE)处产生一灵敏的极谱催化氢波,其二阶导数峰电流与吡洛昔康浓度在2.0×10-8～5.6×10-6mol/L范围内呈线性关系(r=0.9990,n=8),检出限为1.0×10-8mol/L。该方法可用于药剂中吡洛昔康的测定。